← Back to Search

Essential Oil

Peppermint Oil for Bladder and Bowel Dysfunction in Children

N/A
Waitlist Available
Led By Heidi A. Stephany, MD
Research Sponsored by Children's Hospital of Orange County
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial will study if peppermint oil helps improve bladder/bowel dysfunction in children. Participants take oil capsules for 8 weeks & fill out a questionnaire at start/end. Results will determine if there's improvement in symptoms. #peppermintoiltrial

Who is the study for?
This trial is for children aged 8-17 who weigh at least 30kg and have bladder and bowel dysfunction not caused by nerve issues. They should have tried behavioral therapy without success and be able to swallow pills. It's not for kids with certain neurological conditions, severe urinary tract problems, learning disabilities, recent oxybutynin use, or gastrointestinal disorders.Check my eligibility
What is being tested?
The study tests if peppermint oil capsules taken three times daily can improve symptoms of bladder and bowel dysfunction in children. The effectiveness will be measured using a questionnaire before starting treatment and after eight weeks of taking the oil.See study design
What are the potential side effects?
While the trial information doesn't specify side effects, generally peppermint oil can cause heartburn, allergic reactions, flushing, headache and mouth sores when consumed in large doses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Symptom score

Side effects data

From 2015 Phase 2 trial • 8 Patients • NCT02291445
25%
Headache
25%
Altered Fecal Odor
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ileocolonic Release PO
Small Intestinal Release PO

Trial Design

1Treatment groups
Experimental Treatment
Group I: Peppermint OilExperimental Treatment1 Intervention
Peppermint oil will be provided free of charge to participants under the trademark Pepogest produced by the maker Nature's Way® (dosage 0.2 mL, 181 mg peppermint oil).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peppermint Oil
2016
N/A
~50

Find a Location

Who is running the clinical trial?

Children's Hospital of Orange CountyLead Sponsor
32 Previous Clinical Trials
4,904 Total Patients Enrolled
Heidi A. Stephany, MDPrincipal InvestigatorChildren's Hospital, Orange County

Media Library

Peppermint Oil (Essential Oil) Clinical Trial Eligibility Overview. Trial Name: NCT05613153 — N/A
Bladder and Bowel Incontinence Research Study Groups: Peppermint Oil
Bladder and Bowel Incontinence Clinical Trial 2023: Peppermint Oil Highlights & Side Effects. Trial Name: NCT05613153 — N/A
Peppermint Oil (Essential Oil) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05613153 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial actively seeking participants?

"According to details on clinicaltrials.gov, this medical trial has ceased recruiting participants as the date of its last update was November 4th 2022. Although no longer enrolling new candidates, 176 other trials are actively seeking individuals for study participation at present."

Answered by AI

Are individuals 40 years of age or older eligible for participation in this research study?

"As per the study's qualifications, participants must be between 8 and 17 years of age."

Answered by AI

Is it possible to join the ongoing clinical experiment?

"This medical trial is looking for 30 minors, aged 8 to 17 years old and weighing at least 30kgs, that experience non-neurogenic bladder dysfunctions despite having followed the standard urotherapy protocol. Additionally, applicants must be able to swallow pills in order to qualify as participants of this study."

Answered by AI
~10 spots leftby Dec 2024